Technical Analysis for BPTH - Bio-Path Holdings Inc
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 4.86 | 5.65% | 0.26 |
BPTH closed up 5.65 percent on Monday, March 18, 2024, on 1.55 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Calm After Storm | Range Contraction | 0.00% | |
Doji - Bullish? | Reversal | 0.00% | |
New 52 Week Low | Weakness | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | 5.65% | |
Calm After Storm | Range Contraction | 5.65% | |
Stochastic Reached Oversold | Weakness | 5.65% | |
Wide Bands | Range Expansion | 5.65% |
Alert | Time |
---|---|
Rose Above Previous Day's High | about 13 hours ago |
Outside Day | about 13 hours ago |
Up 10% | about 13 hours ago |
60 Minute Opening Range Breakout | about 14 hours ago |
Up 5% | about 14 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/08/2024
Bio-Path Holdings, Inc., a biotechnology company, focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. Its lead product candidate, Liposomal Grb-2, is in a Phase I study for blood cancers and in preclinical studies for triple negative and inflammatory breast cancers. The company's other drug candidate, Liposomal Bcl-2, is ready for the clinic where it would be evaluated in lymphoma and solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Houston, Texas.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Solid Tumors Acid Breast Cancer Lymphoma Cell Biology Treatment Of Breast Cancer Therapeutic Products Oncogenes Blood Cancers Apoptosis
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Solid Tumors Acid Breast Cancer Lymphoma Cell Biology Treatment Of Breast Cancer Therapeutic Products Oncogenes Blood Cancers Apoptosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 44.8 |
52 Week Low | 4.41 |
Average Volume | 21,997 |
200-Day Moving Average | 13.37 |
50-Day Moving Average | 7.94 |
20-Day Moving Average | 6.09 |
10-Day Moving Average | 5.59 |
Average True Range | 0.98 |
RSI (14) | 31.51 |
ADX | 21.87 |
+DI | 18.68 |
-DI | 22.39 |
Chandelier Exit (Long, 3 ATRs) | 6.88 |
Chandelier Exit (Short, 3 ATRs) | 7.36 |
Upper Bollinger Bands | 8.24 |
Lower Bollinger Band | 3.95 |
Percent B (%b) | 0.21 |
BandWidth | 70.45 |
MACD Line | -0.87 |
MACD Signal Line | -0.82 |
MACD Histogram | -0.0523 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 6.50 | ||||
Resistance 3 (R3) | 6.53 | 6.01 | 6.22 | ||
Resistance 2 (R2) | 6.01 | 5.60 | 6.00 | 6.13 | |
Resistance 1 (R1) | 5.44 | 5.34 | 5.73 | 5.41 | 6.04 |
Pivot Point | 4.92 | 4.92 | 5.07 | 4.91 | 4.92 |
Support 1 (S1) | 4.35 | 4.51 | 4.64 | 4.32 | 3.68 |
Support 2 (S2) | 3.83 | 4.25 | 3.82 | 3.59 | |
Support 3 (S3) | 3.26 | 3.83 | 3.50 | ||
Support 4 (S4) | 3.23 |